The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, will cut 9,000 jobs or 11.5 per cent of its workforce in a ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Danish drugmaker warns over slowing growth as Ozempic and Wegovy producer faces pressure from US rival Eli Lilly ...

Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...

This Denmark-headquartered company underestimated demand for its anti-obesity treatment Wegovy when it launched in the U.S.

Novo Nordisk announced an 11% workforce reduction, cutting 9,000 jobs amid rising competition in obesity treatments. The ...

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com. Read more at straitstimes.com.